Join Now

Dash Bio Raises $30M Series A to Accelerate Drug Development Timelines

By Natalie Themm | Published August 6, 2026

Funding Brings Total Raised to $47.5M as Demand Grows for Better Infrastructure to Support Biopharma

Posted in BioUtah News | Tagged | Comments Off on Dash Bio Raises $30M Series A to Accelerate Drug Development Timelines

A Special Thanks To Our Legacy and Platinum Elite Members